Identification of Potential Drug Targets Implicated in Parkinson's Disease from Human Genome: Insights of Using Fused Domains in Hypothetical Proteins as Probes

<table class="table-group" id="tab6"><tr><td><table class="table"><tr><td class="thead-hr" colspan="6"><hr/></td></tr><tr><td align="left" rowspan="2">KEGG sequence</td><td align="center" rowspan="2">
									Hypothetical <br/>protein Gi IDs</td><td align="center" colspan="3">Region of domain fusion with the target</td><td align="center" rowspan="2">Sequence identity in the <br/>fused region</td></tr><tr><td align="center">Cd01492</td><td align="center">Cd01491</td><td align="center">UBA1</td></tr><tr><td align="center" colspan="6"><hr/></td></tr><tr><td align="left">UBA1</td><td align="center">12053109</td><td align="center">13–162</td><td align="center">13–162</td><td align="center">54–162</td><td align="center">52/160 = 32%</td></tr><tr class="table-tr"><td colspan="6"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Conservation of domain fusions in Parkinson’s disease targets and human hypothetical sequences.

International Scholarly Research Notices

tab6

Table 6

Table 6: Identification of Potential Drug Targets Implicated in Parkinson's Disease from Human Genome: Insights of Using Fused Domains in Hypothetical Proteins as Probes 

Table 6 | Identification of Potential Drug Targets Implicated in Parkinson's Disease from Human Genome: Insights of Using Fused Domains in Hypothetical Proteins as Probes 